A Low Dose of Naloxone Added to Ropivacaine Prolongs Femoral Nerve Blockade
Not Applicable
Active, not recruiting
- Conditions
- Diseases of the musculo-skeletal system and connective tissue
- Registration Number
- KCT0004632
- Lead Sponsor
- Dong-A University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Active, not recruiting
- Sex
- All
- Target Recruitment
- 72
Inclusion Criteria
American Society of Anesthesiologists Body Rating Classifications I, II, III
Patients over 18 years old and 80 years old who agreed to participate in the study
Patients undergoing knee joint replacement surgery
Exclusion Criteria
Patients with infection at the site of blockade
Patients with chronic opiate dependence
Patients with pathological obesity (BMI> 35)
Patients with a preceding neurological deficit
Bleeding patients
Patients with allergy to ropivacaine, naloxone
Patients with Uncontrolled Diabetes
pregnant woman
A psychiatric problem
Patient rejection
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain relief period
- Secondary Outcome Measures
Name Time Method Satisfaction score;Side effect